Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $98.02 ($7.0M) on 2015-10-15, disclosed to the SEC on 2015-10-16.
Scheduled sale ($7.0M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.02 | 3,200 | $314K | 4.5% |
| 2 | $99.25 | 26,105 | $2.6M | 37.0% |
| 3 | $99.96 | 15,376 | $1.5M | 21.9% |
| 4 | $101.18 | 25,319 | $2.6M | 36.6% |
| Total | $100.05 avg | 70,000 | $7.0M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |